Clinical response seen for patients with severe asthma initiating biologics

Patients with severe asthma initiating biologics exhibit clinical responses and super-responses, but 40 to 50% do not meet response criteria, according to a study published online June 22 in Allergy. Eve Denton, M.B.B.S., from Alfred Health in Melbourne, Australia, and colleagues examined responsiveness to biologics in a real-world population of adults with severe asthma. Participants in the International Severe Asthma Registry (ISAR) with ?24?weeks of follow-up were categorized as those who initiated or did not initiate biologics. Treatment responses were examined in various domains: forced expiratory volume in one?second (FEV1) Read More

Related posts:

  1. Aerobic exercise tied to improved clinical asthma outcomes
  2. Four in five psychologists overlook dissociation, a common trauma response among patients seeking therapy
  3. Research suggests early life antibiotic increases asthma risk, providing clues to potential prevention of adult asthma
  4. First-of-its-kind clinical trial eliminates or shrinks melanoma tumors in 70% of patients
  5. Researchers say AI accurately screens heart failure patients for clinical trial eligibility
  6. Clinical study shows zebrafish avatars of cancer patients have high predictive power
  7. Backward walking speed reserve assessment offers improved clinical screening for risks and decline in MS patients
  8. New method allows quick measurement of photoreceptor response

Leave a Reply

Your email address will not be published. Required fields are marked *